Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
neuroscience
Arvinas Announces Oral Presentation at 2025 International Conference on Alzheimer’s & Parkinson’s Diseases
27 mars 2025 07h00 HE
|
Arvinas Inc.
NEW HAVEN, Conn., March 27, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein...
Novartis to present new data at AAN, including seven-year disability outcomes and safety analysis of Kesimpta® in people with relapsing multiple sclerosis
25 mars 2025 02h15 HE
|
Novartis Pharma AG
Long-term disability and safety data from ALITHIOS open-label extension study on continuous treatment with Kesimpta vs. later switch from teriflunomide in relapsing multiple sclerosis (RMS) patients...
ANEUVO Launches ASPIRE™ Home Study to Evaluate Home Use of ExaStim®
19 mars 2025 09h11 HE
|
ANEUVO
Los Angeles, CA, March 19, 2025 (GLOBE NEWSWIRE) -- ANEUVO, a leader in non-invasive therapy development, has announced the launch of the ASPIRE™ Home Study, the next phase of clinical research for...
FDA Clears Magstim Transcranial Magnetic Stimulation System for U.S. Adolescent Patient Treatment
19 mars 2025 08h08 HE
|
Magstim EGI
MINNEAPOLIS, March 19, 2025 (GLOBE NEWSWIRE) -- Major depression impacts more than 5 million U.S. adolescents every year, and NIH data shows that 20% of those aged 12 to 16 have had at least one...
Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial
11 mars 2025 06h45 HE
|
Arvinas Inc.
– VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically meaningful improvement in progression-free survival – –...
Neurology Devices Market is Expected to Reach USD 22,335.5 Million by 2035, Growing at 6.7% CAGR | Fact.MR Report
10 mars 2025 07h30 HE
|
FACT.MR
Rockville, MD, March 10, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global neurology devices market is estimated to reach a...
Drs. Jeffrey Lieberman, M.D. and David Sinclair, Ph.D. to Present ‘The New Frontier of Longevity Science: Living Well Beyond Your Years’ at SXSW 2025
07 mars 2025 17h09 HE
|
Dr. Jeffrey Lieberman
Drs. David Sinclair & Jeffrey Lieberman to explore the latest advances in longevity science and emerging new model for living better, longer at SXSW 2025
Arvinas to Participate in Upcoming Investor Conferences
04 mars 2025 16h05 HE
|
Arvinas Inc.
NEW HAVEN, Conn., March 04, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Precision Neuroscience Expands Clinical Research in Brain–Computer Interface Through Collaboration with Beth Israel Deaconess Medical Center
27 févr. 2025 09h00 HE
|
Precision Neuroscience
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation, a pioneering brain–computer interface (BCI) company, today announced a clinical research project with Beth Israel...
Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury
27 févr. 2025 08h00 HE
|
Tiziana Life Sciences Ltd.
Traumatic brain injury is a leading cause of death and disabilityCurrently, there is no treatment to prevent the long-term effects of traumatic brain injuryFindings could translate into treating...